Successfully conducted E&Y cGMP audit in May 2018.    2D barcode printing on all products implemented from May 2018.   Received ISO 9001:2015 Certification in July 2018.   Received ISO 14001:2015 Certification in December 2019.   Received ISO 45001:2018 Certification in December 2020.

Merzel

Brand Name

Merzel

 

Generic Name

Meropenem

Composition

Merzel Injection 500mg IV: Each pack contains:
Vial: Meropenem 500mg (Blended with Sterile Sodium Carbonate).
Ampoule: Sterile water for injection 10mL.
Merzel Injection 1g IV: Each pack contains:
Vial: Meropenem 1g (Blended with Sterile Sodium Carbonate).
Ampoule: Sterile water for injection 10mL (2 Ampoules).

Indications

Complicated skin and skin structure infections (adult patients and pediatric patients 3 months of age and older only)
Merzel IV is indicated for the treatment of complicated skin and skin structure infections due to Staphylococcus aureus (methicillin-susceptible isolates only), Streptococcus pyogenes, Streptococcus agalactiae, viridans group streptococci, Enterococcus faecalis (vancomycin-susceptible isolates only), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis, and Peptostreptococcus species.
Complicated intra-abdominal infections (adult and pediatric patients)
For the treatment of complicated appendicitis and peritonitis caused by viridans group streptococci, Escherichia coli, Klebsiella pneumoniae, pseudomonas aeruginosa, Bacteroides fragilis, B. thetaiotaomicron, and Peptostreptococcus species.
Bacterial meningitis (pediatric patients 3 months of age and older only)
Merzel IV is indicated for the treatment of bacterial meningitis caused by Haemophilus influenzae, Neisseria meningitidis and penicillin-susceptible isolates of Streptococcus pneumoniae. Merzel IV has been found to be effective in eliminating concurrent bacteremia in association with bacterial meningitis.
Usage
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Merzel IV and other antibacterial drugs, Merzel IV should only be used to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy.

Presentation

Merzel 500mg IV Injection 1 vial of 500 mg meropenem and 1 ampoule of 10mL solvent.
Merzel 1g IV Injection 1 vial of 1 g meropenem and 2 ampoules with10mL solvent each.

Product Leaflet

Merzel-insert